AC T04997
XX
ID T04997
XX
DT 07.12.2001 (created); rge.
DT 10.06.2015 (updated); asv.
CO Copyright (C), QIAGEN.
XX
FA p53
XX
SY cellular tumor antigen p53; p53; tp53; tumor suppressor p53.
XX
OS rat, Rattus norvegicus
OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae
XX
GE G009976 Tp53.
XX
CL C0057; P53; 6.3.1.0.1.
XX
IN T25057 alpha-synuclein; human, Homo sapiens.
IN T02113 TAFII31; human, Homo sapiens.
IN T00899 WT1; human, Homo sapiens.
XX
MX M00761 V$P53DECAMER_Q2.
MX M00034 V$P53_01.
MX M00272 V$P53_02.
MX M01651 V$P53_03.
MX M01652 V$P53_04.
MX M01655 V$P53_05.
MX M07054 V$P53_Q3_01.
XX
BS R31279.
BS R29992.
BS R11387.
BS R70605.
BS R70614.
BS R70626.
BS R11722.
BS R11645.
BS R32569.
BS R32570.
BS R25258.
BS R39586.
BS R11701.
BS R11702.
BS R39588.
BS R66444.
BS R59446.
BS R31418.
BS R59287.
BS R68198.
BS R39745.
BS R39748.
BS R31678.
BS R74049.
XX
DR TRANSPATH: MO000028760.
DR TRANSCOMPEL: C00309.
DR TRANSCOMPEL: C00487.
DR UniProtKB: P10361;
XX
RN [1]; RE0016943.
RX PUBMED: 10359011.
RA Ruiz-Lozano P., Hixon M. L., Wagner M. W., Flores A. I., Ikawa S., Baldwin AS J. r., Chien K. R., Gualberto A.
RT p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression.
RL Cell Growth Differ. 10:295-306 (1999).
RN [2]; RE0017395.
RX PUBMED: 3060862.
RA Soussi T., Caron de Fromentel C., Breugnot C., May E.
RT Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein
RL Nucleic Acids Res. 16:11384 (1988).
RN [3]; RE0017396.
RX PUBMED: 8441680.
RA Hulla J. E., Schneider R. P.
RT Structure of the rat p53 tumor suppressor gene
RL Nucleic Acids Res. 21:713-717 (1993).
RN [4]; RE0047681.
RX PUBMED: 9372952.
RA Qi J. S., Desai-Yajnik V., Yuan Y., Samuels H. H.
RT Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression.
RL Mol. Cell. Biol. 17:7195-7207 (1997).
RN [5]; RE0048944.
RX PUBMED: 16481464.
RA Hallstrom T. C., Nevins J. R.
RT Jab1 is a specificity factor for E2F1-induced apoptosis.
RL Genes Dev. 20:613-623 (2006).
RN [6]; RE0049299.
RX PUBMED: 12379483.
RA Qadri I., Iwahashi M., Simon F.
RT Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3.
RL Biochim. Biophys. Acta 1592:193-204 (2002).
RN [7]; RE0049956.
RX PUBMED: 16849690.
RA Wang J., Pabla N., Wang C. Y., Wang W., Schoenlein P. V., Dong Z.
RT Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53.
RL Am. J. Physiol. Renal Physiol. 291:F1300-7 (2006).
RN [8]; RE0050125.
RX PUBMED: 16427076.
RA Zebrowski D. C., Alcendor R. R., Kirshenbaum L. A., Sadoshima J.
RT Caspase-3 mediated cleavage of MEKK1 promotes p53 transcriptional activity.
RL J. Mol. Cell. Cardiol. 40:605-618 (2006).
RN [9]; RE0052977.
RX PUBMED: 9852160.
RA Aloyz R. S., Bamji S. X., Pozniak C. D., Toma J. G., Atwal J., Kaplan D. R., Miller F. D.
RT p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors.
RL J. Cell Biol. 143:1691-1703 (1998).
RN [10]; RE0066926.
RX PUBMED: 19049493.
RA Cuesta A., Zambrano A., Royo M., Pascual A.
RT The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP).
RL Biochem. J. 418:643-650 (2009).
XX
//